March 05, 2018
Safety Analysis of Leishmania Vaccine Used in a Randomized Canine Vaccine/Immunotherapy Trial
In Leishmania infantum–endemic countries, controlling infection within dogs, the domestic reservoir, is critical to public health. There is a need for safe vaccines that prevent canine progression with disease and transmission to others. Protective vaccination against Leishmania requires mounting a strong, inflammatory, Type 1 response. Three commercially available canine vaccines on the global veterinary market use saponin or inflammatory antigen components (Letifend) as a strong pro-inflammatory adjuvant. There is very little information detailing safety of saponin as an adjuvant in field trials. Safety analyses for the use of vaccine as an immunotherapeutic in asymptomatically infected animals are completely lacking. Leishmania infantum, the causative agent of canine leishmaniasis, is enzootic within U.S. hunting hounds. We assessed the safety of LeishTec® after use in dogs from two different clinical states: 1) without clinical signs and tested negative on polymerase chain reaction and serology or 2) without clinical signs and positive for at least one Leishmania diagnostic test. Vaccine safety was assessed after all three vaccinations to quantify the number and severity of adverse events. Vaccinated animals had an adverse event rate of 3.09%, whereas placebo animals had 0.68%. Receiving vaccine was correlated with the occurrence of mild, site-specific, reactions. Occurrence of severe adverse events was not associated with having received vaccine. Infected, asymptomatic animals did not have a higher rate of adverse events. Use of vaccination is, therefore, likely to be safe in infected, asymptomatic animals.
Read the full article in The American of Tropical Medicine and Hygiene.
More from CNAS
-
How the War on Iran Threatens the Global Economy
Commentary
This article was originally published in TIME. Around two weeks into the American and Israeli war with Iran, the economic, political, and military costs of the conflict for th...
By Becca Wasser
-
Congressional Testimony
Defense / Middle East Security
Iran War Could Hinge On Who Runs Low On Munitions FirstIn just days of attacks, the US has used weapons stores that could take years to rebuild. On today’s Big Take podcast, Sarah Holder sits down with global defense editor Gerry ...
By Becca Wasser
-
Commentary
Defense / Middle East Security
Iran’s Cheap, Plentiful Weaponry Puts U.S. Military Under Unprecedented StrainThis article was originally published in Bloomberg. When the first cruise missiles began detonating inside Iran, the strikes had all the hallmarks of previous successful U.S. ...
By Becca Wasser
-
Video
Defense / Middle East Security
Trump Threatens Iran over Strait of HormuzCenter for a New American Security program director Stacie Pettyjohn joined BBC News to discuss the war in Iran, Iranian attempts to mine the Strait of Hormuz, and the challen...
By Stacie Pettyjohn
